NASDAQ:AFIB Acutus Medical (AFIB) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsSEC Filings About Acutus Medical Stock (NASDAQ:AFIB) Get Acutus Medical alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume7,092 shsMarket Capitalization$3 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Acutus Medical, Inc. was a medical technology company focused on developing products for the diagnosis and treatment of cardiac arrhythmias, particularly atrial fibrillation. The company’s technologies were designed for use by cardiac electrophysiologists during minimally invasive catheter-based procedures. Its primary product platform was the AcQMap High Resolution Imaging and Mapping System, which combined ultrasound imaging with electrical mapping to create three-dimensional models of the heart and help physicians identify abnormal electrical activity. Acutus also developed related electrophysiology products, including mapping catheters and tools intended to support transseptal access and cardiac ablation procedures. Founded in 2011 and headquartered in Carlsbad, California, Acutus served hospitals and electrophysiology centers in the United States and international markets, including Europe. The company later underwent significant restructuring, and Medtronic acquired certain Acutus assets and technologies. As a result, Acutus Medical is primarily of historical interest as an independent publicly traded company and developer of cardiac mapping technologies.AI Generated. May Contain Errors. Read More Receive AFIB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Acutus Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AFIB Stock News HeadlinesAcutus Medical consensus price target lowered by 66.67% to $0.51November 2 at 8:33 PM | msn.comAFIB Acutus Medical, Inc. - Seeking AlphaJuly 1, 2025 | seekingalpha.comU.S. Army Advances 75-Year Rare Earth Deal With Nasdaq FirmThe Pentagon is moving to cut US dependence on Chinese rare earth metals, and a Nasdaq-listed company just signed a term sheet for a potential 75-year agreement with the US Army. The proposed deal would let the company build and operate a rare earth processing facility on an active military base, with the Army getting first right to production. New Pentagon restrictions on Chinese-origin rare earth magnets take effect January 1, 2027. The company's mine-to-magnet platform covers feedstock agreements, processing, metallization, and downstream manufacturing, with commercial output targeted for 2027.November 4 at 1:00 AM | The Tomorrow Investor (Ad)EnChannel Medical to Acquire Acutus Medical AcQMap™ Electrophysiology AssetsJuly 1, 2025 | finance.yahoo.comAcutus Medical Stock Short Interest Report | OTC:AFIB | BenzingaMay 26, 2025 | benzinga.comAcutus Medical Reports Full Year 2024 Financial ResultsMarch 24, 2025 | globenewswire.comAcutus Medical Announces Operational DownsizingDecember 4, 2024 | globenewswire.comAcutus Medical Reports Q3 2024 Financial ResultsNovember 20, 2024 | markets.businessinsider.comSee More Headlines AFIB Stock Analysis - Frequently Asked Questions How were Acutus Medical's earnings last quarter? Acutus Medical, Inc. (NASDAQ:AFIB) posted its earnings results on Thursday, November, 11th. The company reported ($0.94) earnings per share for the quarter, missing the consensus estimate of ($0.92) by $0.02. The company had revenue of $4.60 million for the quarter, compared to analysts' expectations of $6.02 million. Acutus Medical had a negative net margin of 272.74% and a negative trailing twelve-month return on equity of 311.64%. Does Acutus Medical have any subsidiaries? Acutus Medical subsidiaries include these companies: Acutus Medical N.V.. When did Acutus Medical IPO? Acutus Medical (AFIB) raised $126 million in an initial public offering on Thursday, August 6th 2020. The company issued 7,400,000 shares at a price of $16.00-$18.00 per share. J.P. Morgan, BofA Securities and William Blair served as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers. What other stocks do shareholders of Acutus Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Acutus Medical investors own include Walt Disney (DIS), Moderna (MRNA), NVIDIA (NVDA), Shopify (SHOP), AMC Entertainment (AMC), Alibaba Group (BABA) and Salesforce (CRM). Company Calendar Last Earnings11/11/2021Today11/04/2026Next Earnings (Estimated)11/13/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:AFIB CIK1522860 Webwww.acutusmedical.com Phone442-232-6080Fax442-232-6081Employees85Year Founded2011Profitability EPS (Trailing Twelve Months)($0.11) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$81.66 million Net Margins-272.74% Pretax Margin-30.32% Return on Equity-311.64% Return on Assets-11.57% Debt Debt-to-Equity RatioN/A Current Ratio1.85 Quick Ratio1.57 Sales & Book Value Annual Sales$7.16 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value($0.03) per share Price / BookN/AMiscellaneous Outstanding Shares29,912,000Free Float28,228,000Market Cap$3 thousand OptionableNo Data Beta5.71 Social Links 7 Energy Stocks to Buy and Hold ForeverOil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.Get This Free Report This page (NASDAQ:AFIB) was last updated on 11/3/2026 by MarketBeat.com Staff. From Our PartnersI'm handing you this one freeElon Musk doesn't own the chip powering every Tesla, every Starlink dish, and every AI satellite he builds, he...Behind the Markets | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredMany investors are about to lose everythingTwenty five years ago, this analyst predicted the fiber optic boom and called Amazon before it became a househ...Porter & Company | SponsoredU.S. Army Advances 75-Year Rare Earth Deal With Nasdaq FirmThe Pentagon is moving to cut US dependence on Chinese rare earth metals, and a Nasdaq-listed company just sig...The Tomorrow Investor | SponsoredElon Musk about to bankrupt Amazon, Microsoft & Google?Jeff Brown, the former tech executive who called the rise of Bitcoin, Tesla, and Nvidia years early, is tracki...Brownstone Research | SponsoredLast call for your free 0DTE reportThe 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, p...Profits Run | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredTesla pays $0 in dividends. This new fund paid $452 in one month on $5,000.Tesla has never paid shareholders a dividend, not one cent. A new fund built on Tesla's stock takes a differen...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acutus Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acutus Medical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
